With winter coming, China broadens emergency use of vaccines
China has approved several locally developed Covid-19 vaccines under emergency use authorizations, Reuters reported last week.
According to sources familiar with the matter, Sinovac Biotech’s inactivated vaccine candidate, CoronaVac, was approved in July for emergency use for people at high risk of contracting the novel coronavirus, a group that includes medical staff. State-owned drug maker Sinopharm also announced through its social media platform on WeChat that its vaccine candidate – still in Phase 3 testing in several foreign countries – is cleared for emergency use for high-risk personnel.
Fearing that a new wave of Covid-19 will arrive in the fall and winter, Chinese health officials told state media last week that the government began expanding its emergency use program to stay ahead of the virus.
According to sources familiar with the matter, Sinovac Biotech’s inactivated vaccine candidate, CoronaVac, was approved in July for emergency use for people at high risk of contracting the novel coronavirus, a group that includes medical staff. State-owned drug maker Sinopharm also announced through its social media platform on WeChat that its vaccine candidate – still in Phase 3 testing in several foreign countries – is cleared for emergency use for high-risk personnel.
Fearing that a new wave of Covid-19 will arrive in the fall and winter, Chinese health officials told state media last week that the government began expanding its emergency use program to stay ahead of the virus.
No hay comentarios:
Publicar un comentario